Cargando…
Peptide-Based Technologies to Alter Adenoviral Vector Tropism: Ways and Means for Systemic Treatment of Cancer
Due to the fundamental progress in elucidating the molecular mechanisms of human diseases and the arrival of the post-genomic era, increasing numbers of therapeutic genes and cellular targets are available for gene therapy. Meanwhile, the most important challenge is to develop gene delivery vectors...
Autores principales: | Reetz, Julia, Herchenröder, Ottmar, Pützer, Brigitte M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014709/ https://www.ncbi.nlm.nih.gov/pubmed/24699364 http://dx.doi.org/10.3390/v6041540 |
Ejemplares similares
-
Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo
por: Reetz, Julia, et al.
Publicado: (2013) -
Correction: Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo
por: Reetz, Julia, et al.
Publicado: (2013) -
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010) -
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
por: Tessarollo, Nayara Gusmão, et al.
Publicado: (2021) -
CELO Fiber1 Knob Is a Promising Candidate to Modify the Tropism of Adenoviral Vectors
por: Sun, Yangyang, et al.
Publicado: (2022)